XFOR

3.0101.69%
MJ

Michael J. Vasconcelles

Member of Corporate Advisory Board

Dr. Michael J. Vasconcelles, M.D., Ph.D., also known as Mike, serves as an Independent Director at MacroGenics, Inc. since October 30, 2026. He is Head of Research & Development of Day One Biopharmaceuticals, Inc. from June 2025. Dr. Vasconcelles is Executive VP of Research, Development & Medical Affairs and Chief Medical Officer of ImmunoGen, Inc. Dr. Vasconcelles joined the ImmunoGen, Inc. on December 29, 2022. Dr. Vasconcelles was Chief Medical Officer of ImmunoGen, Inc. from August 31, 2023. Dr. Vasconcelles was Executive VP of Research, Development & Medical Affairs of ImmunoGen, Inc. from December 29, 2022 to August 31, 2023. Dr. Vasconcelles is Independent Director of Molecular Partners AG from April 29, 2020. Dr. Vasconcelles is Independent Director of Kura Oncology, Inc. from September 2024. Dr. Vasconcelles is Member of Corporate Advisory Board of X4 Pharmaceuticals, Inc. Dr. Vasconcelles joined the X4 Pharmaceuticals, Inc. on April 04, 2016. Dr. Vasconcelles is Member of Scientific Advisory Board of Mythic Therapeutics, Inc. Dr. Vasconcelles is Member of Scientific Advisory Board of Cogent Biosciences, Inc. Dr. Vasconcelles was Senior Advisor of Frazier Life Sciences Management, LP until June 2025. Dr. Vasconcelles is Clinical Advisor of Serum Detect, Inc. Dr. Vasconcelles was Senior Advisor of Frazier Management, L.L.C. from April 2019. Dr. Vasconcelles joined the Frazier Management, L.L.C. in April 2019. Dr. Vasconcelles focused on Life science. Dr. Vasconcelles was Head of Oncology Therapeutic Area Unit and Senior Vice President of Millennium Pharmaceuticals, Inc. Dr. Vasconcelles was employed at Millennium Pharmaceuticals, Inc. until 2015. Dr. Vasconcelles was Chief Medical Officer of Flatiron Health, Inc. from August 2019 to June 2022. Dr. Vasconcelles was employed at Flatiron Health, Inc. until June 2022. Dr. Vasconcelles was Advisor of Unum Therapeutics Inc. from July 15, 2019. Dr. Vasconcelles was Chief Medical Officer of Unum Therapeutics Inc. from October 2015 to July 15, 2019. Dr. Vasconcelles joined the Unum Therapeutics Inc. on October 21, 2015. Dr. Vasconcelles was Director of Magenta Therapeutics, Inc. from August 2022. Dr. Vasconcelles was Independent Director of Dianthus Therapeutics, Inc. until September 11, 2023. Dr. Vasconcelles was employed at Dianthus Therapeutics, Inc. until September 11, 2023. During the period from 1996-2021, Dr. Vasconcelles held a faculty appointment at the Harvard Medical School, where he completed all of his postgraduate training and was an associate physician at the Beth Israel Hospital, the Brigham and Women's Hospital and the Dana-Farber Cancer Institute. Dr. Vasconcelles has B.A. from Northwestern University, Ph.D. from West Virginia University, M.D. from Northwestern University, Feinberg School of Medicine.

Positions